BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Young MJ, Kanki M, Karthigan N, Konstandopoulos P. The role of the mineralocorticoid receptor and mineralocorticoid-receptor-directed therapies in heart failure. Endocrinology 2021:bqab105. [PMID: 34050730 DOI: 10.1210/endocr/bqab105] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Lorente-Ros M, Aguilar-Gallardo JS, Shah A, Narasimhan B, Aronow WS. An overview of mineralocorticoid receptor antagonists as a treatment option for patients with heart failure: the current state-of-the-art and future outlook. Expert Opin Pharmacother 2022. [PMID: 36262014 DOI: 10.1080/14656566.2022.2138744] [Reference Citation Analysis]
2 Hattori M, Rahman A, Kidoguchi S, Jahan N, Fujisawa Y, Morisawa N, Ohsaki H, Kobara H, Masaki T, Hossain A, Steeve A, Nishiyama A. Association of Antihypertensive Effects of Esaxerenone with the Internal Sodium Balance in Dahl Salt-Sensitive Hypertensive Rats. IJMS 2022;23:8915. [DOI: 10.3390/ijms23168915] [Reference Citation Analysis]
3 Chen G, Chang Y, Xiong Y, Hao J, Liu L, Liu Z, Li H, Qiang P, Han Y, Xian Y, Shimosawa T, Wang X, Yang F, Xu Q. Eplerenone inhibits UUO-induced lymphangiogenesis and cardiac fibrosis by attenuating inflammatory injury. International Immunopharmacology 2022;108:108759. [DOI: 10.1016/j.intimp.2022.108759] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Morales M, Martín-vasallo P, Ávila J. Genetic Profiling of Glucocorticoid (NR3C1) and Mineralocorticoid (NR3C2) Receptor Polymorphisms before Starting Therapy with Androgen Receptor Inhibitors: A Study of a Patient Who Developed Toxic Myocarditis after Enzalutamide Treatment. Biomedicines 2022;10:1271. [DOI: 10.3390/biomedicines10061271] [Reference Citation Analysis]
5 Young MJ, Clyne CD. Mineralocorticoid receptor actions in cardiovascular development and disease. Essays Biochem 2021:EBC20210006. [PMID: 34414409 DOI: 10.1042/EBC20210006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
6 Gomez-Sanchez CE, Gomez-Sanchez EP. The Mineralocorticoid Receptor and the Heart. Endocrinology 2021:bqab131. [PMID: 34175946 DOI: 10.1210/endocr/bqab131] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]